Anabolic Steroids Market Trends

  • Report ID: 5986
  • Published Date: May 10, 2025
  • Report Format: PDF, PPT

Anabolic Steroids Sector: Growth Drivers and Challenges

Growth Drivers

  • The Prevalence of Hypogonadism in Men is Rising- The growing incidence of hypogonadism in men will drive the anabolic steroids market expansion. It is estimated that between 30 and 50 percent of men with type 2 diabetes or obesity and 35 percent of males over 45 have hypogonadism. A low level of testosterone in males causes hypogonadism, which impairs their quality of life and the function of many organs. The main reasons of male impotence are exhaustion, sleep deprivation, worry, and binge drinking. Breast cancer is the result of women's breast cells developing out of control. These cells develop into a tumor, which appears as an X-ray or can be felt as a bump. The infection of adjacent tissues by these cells leads to malignant malignancy.

  • Infrastructure Spending in the Healthcare Sector is Rising- The increasing cost of healthcare, which contributes to the development of the industry's infrastructure, is another important factor impacting the anabolic steroids market growth rate. Additionally, by boosting funding, a number of government groups hope to strengthen the healthcare infrastructure, which would further alter the dynamics of the market.
  • Growing Popularity Among Youth for Bodybuilding- A primary driver of the anabolic steroid business is the increasing adolescent interest in bodybuilding. The performance-enhancing drug that is used worldwide is called steroids. The rise in athletic events has led to a sharp increase in the demand for steroids, which is good news for the worldwide steroid business. Steroids can promote the growth of facial and pubic hair. It enhances ambition and focus while also deepening the voice. Steroids are therefore advantageous for overly feminine hormones. In the US, an estimated 43% of gym patrons participate in bodybuilding exercises.

Challenges

  • Long-term usage of steroids might have the following side effects- Use of AAS for extended periods of time may harm the immune system. Elevated blood pressure is a typical side effect of AAS, particularly in people who already have hypertension. According to studies, persons who use steroids regularly are more likely to develop cardiovascular diseases. Acne, seborrhea, excessive body hair development, androgenic alopecia, irregular menstruation, and many more are other related side effects. Thus, improper usage of anabolic steroids might have negative consequences on a person and prevent their progress globally.

  • The overuse and abuse of anabolic steroids, particularly in the context of sports and bodybuilding, is one of the main issues facing this anabolic steroids market.  
  • The usage of anabolic steroids can have a number of harmful health repercussions, including heart disease, liver damage, kidney issues, and mental difficulties. This is especially the case when the steroids are taken for extended periods of time or in excess.

Base Year

2024

Forecast Year

2025-2037

CAGR

10.1%

Base Year Market Size (2024)

USD 16.42 billion

Forecast Year Market Size (2037)

USD 57.36 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Anabolic Steroids Market in 2025 is evaluated at USD 17.75 billion.

The global market size was more than USD 16.42 billion in 2024 and is anticipated to grow at a CAGR of over 10.1%, reaching USD 57.36 billion revenue by 2037.

North America is estimated to collect USD 18.93 billion by 2037, due to rising breast cancer incidence and healthcare spend.

The major players in the market include Mylan N.V., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Merck & Co., Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos